'The intranasal vaccine is dropped into the nostril of a person and it gradually slips into the respiratory tract. He also said that prior to the administration of the intranasal vaccine the second time, saliva and blood samples will be collected for studying immunogenicity. Those administered vaccines will now report after 28 days and the same procedure will be repeated. The volunteer was then observed for any reaction for over an hour before being allowed to go home.' This way a total of eight vaccine drops was administered to each person. After a gap of five minutes two more drops were administered in the same fashion. All the volunteers are under observation.ĭr Kushwaha, who administered the vaccine to the volunteers, said, 'Two drops of the intranasal vaccine were put into each nostril of a volunteer. Kushwaha said that the doses of the vaccine administered to healthy volunteers in this phase of trial have been well tolerated and no serious adverse events have been reported. Principal investigator for intranasal Covid vaccine, Dr J.S. The second dose of the vaccine will be administered after 28 days to the volunteers.Īll the volunteers who were administered nasal vaccine are adults. As many as 30 volunteers including doctors, their family members and others have administered the first dose of the intranasal vaccine.Īnother 20 people will be administered this vaccine over the next few days.

Axis phase 2 destiny